FDA 483 - Proactive Medical Products - November 09, 2021

An FDA inspection of Proactive Medical Products in Mount Vernon, NY, a medical device manufacturer and importer, revealed significant deficiencies in their quality system. The firm failed to maintain written procedures for serious incident handling, conduct regular quality audits, and ensure management review of the quality system's effectiveness. These issues indicate a lack of fundamental controls over their operations.